Leaders of New York's major research universities and institutions are urging state lawmakers quickly establish a fund to support stem cell research.
Presidents and chancellors representing 17 New York state universities and institutions -- all with substantial biomedical and life sciences research programs -- Tuesday released a comprehensive analysis of scientific, therapeutic and economic issues and their implications for the state's biomedical research community and economy.
"Recognizing the enormous potential of stem cells, Mount Sinai School of Medicine has, with a generous philanthropic gift, created the Black Family Stem Cell Institute to establish a world-class research program in stem cell biology and medicine," said Dr. Kenneth Davis, president of the Mount Sinai Medical Center.
"If New York is to be counted among the elite group of leaders in biomedical research in the years to come, a large-scale, centralized effort is needed today or we risk losing our intellectual capital, and, thus, our potential," said Davis
Federal funding restrictions on such research have prompted several states to establish state-based research funds. California, New Jersey, Connecticut, Massachusetts, and Maryland are among states that have or are in the process of establishing similar funds.
Copyright 2006 by United Press International
Related stories:
Scientists create 20 disease-specific stem cell lines
(PhysOrg.com) -- Harvard Stem Cell Institute researcher George Q. Daley, associate director of the Stem Cell Program at Children's Hospital Boston, has with HSCI colleagues Chad Cowan and Konrad Hochedlinger of Massachusetts General Hospital produced a robust new collection of disease-specific stem cell lines, all of which were developed using the new induced pluripotent stem cell (iPS) technique. The work is described in a paper published in today's online edition of the journal
Cell.
Putting microRNAs on the stem cell map
Embryonic stem cells are always facing a choice—either to self-renew or begin morphing into another type of cell altogether. It's a tricky choice, governed by complex gene regulatory circuitry driven by a handful of key regulators known as "master transcription factors," proteins that switch gene expression on or off.
Recipe for cell reprogramming adds protein
A drug-like molecule called Wnt can be substituted for the cancer gene c-Myc, one of four genes added to adult cells to reprogram them to an embryonic-stem-cell-like state, according to Whitehead researchers. Researchers hope that such embryonic stem-cell-like cells, known as induced pluripotent (IPS) cells, eventually may treat diseases such as Parkinson's disease and diabetes.
New technique produces genetically identical stem cells
Adult cells of mice created from genetically reprogrammed cells—so-called induced pluripotent stem (IPS) stem cells—can be triggered via drug to enter an embryonic-stem-cell-like state, without the need for further genetic alteration.
Wealth of genomic hotspots discovered in embryonic stem cells
In a paper published in
Cell on June 13, 2008, Singapore scientists at the Genome Institute of Singapore (GIS) and the National University of Singapore (NUS) unveil an atlas that showing the location of "genomic hotspots" of essential protein "switches" (transcription factors) that are critical for maintaining the embryonic stem (ES) cell state.
Brightest X-ray Vision at the Nano-scale
Technology-development studies at Cornell University and Jefferson Laboratory are showing how to use the brightest X-ray light ever generated for the scientific examination of everything from human proteins to forged art.
Mixing and matching genes to keep nerve cells straight
With fewer than 30,000 human genes with which to work, Nature has to mix and match to generate the myriad types of neurons or nerve cells needed to assemble the brain and nervous system. Keeping this involved process on the straight and narrow requires a clever balance of promotion and inhibition, said researchers from Baylor College of Medicine in Houston in a report that appears in the current edition of the journal
Developmental Cell.
Public funding impacts progress of human embryonic stem cell research
Bolstered by supportive policies and public research dollars, the United Kingdom, Israel, China, Singapore and Australia are producing unusually large shares of human embryonic stem cell research, according to a report from the Georgia Institute of Technology in the June 2008 issue
Cell Stem Cell. Aaron Levine, assistant professor of public policy and author of the book Cloning: A Beginner's Guide, studied how countries output of research papers related to human embryonic stem cell research compared to their output in less contentious fields. He found that even though the United States still puts out far more research in this field than any other single country, when one compares the amount of research in human embryonic stem cells to other forms of research in molecular biology and genetics, the U.S. lags behind.